Komori
Governance4527ROHTO PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Independent Officer Notification Form

The Independent Officer Notification Form was submitted because proposals for the election of outside officers will be submitted to the annual shareholders meeting. All 8 outside officers, comprising 5 outside directors and 3 outside corporate auditors, have been reported as independent officers.

Worth reading
16Immaterial
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
8
people (independent officers)
Wording
Definitive
How definitive the wording is.

Governance structure

Number of directors5 outside directors. The total number of directors is Not disclosed
Number of independent officers8Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

The Independent Officer Notification Form was submitted because proposals for the election of outside officers will be submitted to the annual shareholders meeting. All outside officers who meet the eligibility requirements for independent officer status have been designated as independent officers.

Governance structure
ItemDetails
Number of directors5 outside directors. The total number of directors is Not disclosed
Number of independent officers8 independent officers
Changes this timeThe Independent Officer Notification Form was submitted because proposals for the election of outside officers will be submitted to the annual shareholders meeting. All outside officers who meet the eligibility requirements for independent officer status have been designated as independent officers.
Items this document does not state (5)
Corporate Governance StructureCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because a proposal to elect outside officers will be submitted to the annual general meeting.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | ROHTO PHARMACEUTICAL CO.,LTD. (4527) timely disclosure | Komori